Polymorphisms in drug metabolism genes,
โ
Beth O. Van Emburgh; Jennifer J. Hu; Edward A. Levine; Libyadda J. Mosley; L. Do
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 146 KB
๐ 1 views
## Abstract Polymorphisms in phase I and phase II enzymes may enhance the occurrence of mutations at critical tumor suppressor genes, such as __p53__, and increase breast cancer risk by either increasing the activation or detoxification of carcinogens and/or endogenous estrogens. We analyzed polymo